nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—DDC—telencephalic ventricle—germ cell cancer	0.0476	0.11	CbGeAlD
Methyldopa—DDC—pineal body—germ cell cancer	0.0413	0.0951	CbGeAlD
Methyldopa—COMT—telencephalic ventricle—germ cell cancer	0.0314	0.0725	CbGeAlD
Methyldopa—DDC—ganglion—germ cell cancer	0.0296	0.0682	CbGeAlD
Methyldopa—Myocarditis—Ifosfamide—germ cell cancer	0.0251	0.0489	CcSEcCtD
Methyldopa—Norepinephrine—POU5F1—germ cell cancer	0.0224	0.422	CrCbGaD
Methyldopa—Dopamine—POU5F1—germ cell cancer	0.0209	0.393	CrCbGaD
Methyldopa—COMT—ganglion—germ cell cancer	0.0196	0.0451	CbGeAlD
Methyldopa—Pericarditis—Ifosfamide—germ cell cancer	0.0142	0.0276	CcSEcCtD
Methyldopa—DDC—embryo—germ cell cancer	0.014	0.0324	CbGeAlD
Methyldopa—DDC—brainstem—germ cell cancer	0.0129	0.0297	CbGeAlD
Methyldopa—DDC—telencephalon—germ cell cancer	0.0114	0.0263	CbGeAlD
Methyldopa—COMT—trigeminal ganglion—germ cell cancer	0.00962	0.0222	CbGeAlD
Methyldopa—COMT—brainstem—germ cell cancer	0.00851	0.0196	CbGeAlD
Methyldopa—DDC—adrenal gland—germ cell cancer	0.00831	0.0191	CbGeAlD
Methyldopa—COMT—eye—germ cell cancer	0.00828	0.0191	CbGeAlD
Methyldopa—Tenderness—Bleomycin—germ cell cancer	0.00822	0.016	CcSEcCtD
Methyldopa—DDC—midbrain—germ cell cancer	0.0082	0.0189	CbGeAlD
Methyldopa—COMT—telencephalon—germ cell cancer	0.00755	0.0174	CbGeAlD
Methyldopa—Endocrine disorder—Ifosfamide—germ cell cancer	0.00739	0.0144	CcSEcCtD
Methyldopa—COMT—skin of body—germ cell cancer	0.00721	0.0166	CbGeAlD
Methyldopa—DDC—endocrine gland—germ cell cancer	0.0072	0.0166	CbGeAlD
Methyldopa—COMT—decidua—germ cell cancer	0.00716	0.0165	CbGeAlD
Methyldopa—DDC—head—germ cell cancer	0.00711	0.0164	CbGeAlD
Methyldopa—Tenderness—Ifosfamide—germ cell cancer	0.00703	0.0137	CcSEcCtD
Methyldopa—Amenorrhoea—Ifosfamide—germ cell cancer	0.00698	0.0136	CcSEcCtD
Methyldopa—DDC—testis—germ cell cancer	0.00687	0.0158	CbGeAlD
Methyldopa—Pericarditis—Methotrexate—germ cell cancer	0.0067	0.0131	CcSEcCtD
Methyldopa—COMT—gonad—germ cell cancer	0.0063	0.0145	CbGeAlD
Methyldopa—Vasculitis—Ifosfamide—germ cell cancer	0.00628	0.0122	CcSEcCtD
Methyldopa—Liver injury—Cisplatin—germ cell cancer	0.00628	0.0122	CcSEcCtD
Methyldopa—COMT—uterus—germ cell cancer	0.00626	0.0144	CbGeAlD
Methyldopa—COMT—pituitary gland—germ cell cancer	0.00615	0.0142	CbGeAlD
Methyldopa—Tenderness—Cisplatin—germ cell cancer	0.00606	0.0118	CcSEcCtD
Methyldopa—COMT—medulla oblongata—germ cell cancer	0.00593	0.0137	CbGeAlD
Methyldopa—Colitis—Ifosfamide—germ cell cancer	0.00589	0.0115	CcSEcCtD
Methyldopa—COMT—adrenal gland—germ cell cancer	0.00549	0.0127	CbGeAlD
Methyldopa—COMT—midbrain—germ cell cancer	0.00542	0.0125	CbGeAlD
Methyldopa—SLC15A1—endocrine gland—germ cell cancer	0.00536	0.0123	CbGeAlD
Methyldopa—COMT—bone marrow—germ cell cancer	0.00531	0.0122	CbGeAlD
Methyldopa—COMT—spinal cord—germ cell cancer	0.00529	0.0122	CbGeAlD
Methyldopa—Hepatocellular injury—Cisplatin—germ cell cancer	0.00528	0.0103	CcSEcCtD
Methyldopa—Angina pectoris—Vinblastine—germ cell cancer	0.00519	0.0101	CcSEcCtD
Methyldopa—DDC—brain—germ cell cancer	0.00515	0.0119	CbGeAlD
Methyldopa—COMT—female gonad—germ cell cancer	0.00512	0.0118	CbGeAlD
Methyldopa—Norepinephrine—SLC22A3—germ cell cancer	0.00511	0.0961	CrCbGaD
Methyldopa—Pancytopenia—Vinblastine—germ cell cancer	0.00506	0.00986	CcSEcCtD
Methyldopa—DDC—lymph node—germ cell cancer	0.00498	0.0115	CbGeAlD
Methyldopa—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00493	0.00961	CcSEcCtD
Methyldopa—ADRA2A—trigeminal ganglion—germ cell cancer	0.0049	0.0113	CbGeAlD
Methyldopa—COMT—endocrine gland—germ cell cancer	0.00476	0.011	CbGeAlD
Methyldopa—Dopamine—SLC22A3—germ cell cancer	0.00475	0.0893	CrCbGaD
Methyldopa—COMT—head—germ cell cancer	0.0047	0.0108	CbGeAlD
Methyldopa—COMT—testis—germ cell cancer	0.00454	0.0105	CbGeAlD
Methyldopa—Liver function test abnormal—Dactinomycin—germ cell cancer	0.00448	0.00874	CcSEcCtD
Methyldopa—Agranulocytosis—Vinblastine—germ cell cancer	0.00443	0.00864	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00437	0.00852	CcSEcCtD
Methyldopa—Psychotic disorder—Ifosfamide—germ cell cancer	0.00435	0.00847	CcSEcCtD
Methyldopa—Bone marrow depression—Methotrexate—germ cell cancer	0.0043	0.00837	CcSEcCtD
Methyldopa—Pancytopenia—Bleomycin—germ cell cancer	0.00427	0.00833	CcSEcCtD
Methyldopa—Liver disorder—Methotrexate—germ cell cancer	0.00425	0.00829	CcSEcCtD
Methyldopa—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00425	0.00828	CcSEcCtD
Methyldopa—Cardiac failure congestive—Cisplatin—germ cell cancer	0.00423	0.00825	CcSEcCtD
Methyldopa—Nasal congestion—Cisplatin—germ cell cancer	0.00421	0.00821	CcSEcCtD
Methyldopa—COMT—cerebellum—germ cell cancer	0.0042	0.00967	CbGeAlD
Methyldopa—Breast disorder—Ifosfamide—germ cell cancer	0.00402	0.00784	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00401	0.00781	CcSEcCtD
Methyldopa—Pancytopenia—Dactinomycin—germ cell cancer	0.00399	0.00777	CcSEcCtD
Methyldopa—Cardiac failure congestive—Etoposide—germ cell cancer	0.00387	0.00756	CcSEcCtD
Methyldopa—ADRA2A—telencephalon—germ cell cancer	0.00385	0.00886	CbGeAlD
Methyldopa—Pancreatitis—Ifosfamide—germ cell cancer	0.00377	0.00735	CcSEcCtD
Methyldopa—Angina pectoris—Ifosfamide—germ cell cancer	0.00375	0.0073	CcSEcCtD
Methyldopa—Pancytopenia—Ifosfamide—germ cell cancer	0.00365	0.00712	CcSEcCtD
Methyldopa—ADRA2A—decidua—germ cell cancer	0.00364	0.0084	CbGeAlD
Methyldopa—Orthostatic hypotension—Cisplatin—germ cell cancer	0.0035	0.00683	CcSEcCtD
Methyldopa—Agranulocytosis—Dactinomycin—germ cell cancer	0.00349	0.00681	CcSEcCtD
Methyldopa—Breast disorder—Cisplatin—germ cell cancer	0.00347	0.00676	CcSEcCtD
Methyldopa—Infestation—Ifosfamide—germ cell cancer	0.00343	0.00669	CcSEcCtD
Methyldopa—Infestation NOS—Ifosfamide—germ cell cancer	0.00343	0.00669	CcSEcCtD
Methyldopa—COMT—brain—germ cell cancer	0.00341	0.00785	CbGeAlD
Methyldopa—Hepatitis—Dactinomycin—germ cell cancer	0.00336	0.00655	CcSEcCtD
Methyldopa—Leukopenia—Vinblastine—germ cell cancer	0.00332	0.00648	CcSEcCtD
Methyldopa—COMT—lymph node—germ cell cancer	0.00329	0.00759	CbGeAlD
Methyldopa—Pancreatitis—Cisplatin—germ cell cancer	0.00325	0.00634	CcSEcCtD
Methyldopa—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00324	0.00632	CcSEcCtD
Methyldopa—ADRA2A—gonad—germ cell cancer	0.00321	0.0074	CbGeAlD
Methyldopa—Agranulocytosis—Ifosfamide—germ cell cancer	0.0032	0.00624	CcSEcCtD
Methyldopa—ADRA2A—uterus—germ cell cancer	0.00319	0.00735	CbGeAlD
Methyldopa—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00316	0.00617	CcSEcCtD
Methyldopa—Pancytopenia—Cisplatin—germ cell cancer	0.00315	0.00614	CcSEcCtD
Methyldopa—Bradycardia—Ifosfamide—germ cell cancer	0.00313	0.00611	CcSEcCtD
Methyldopa—ADRA2A—pituitary gland—germ cell cancer	0.00313	0.00722	CbGeAlD
Methyldopa—Hepatitis—Ifosfamide—germ cell cancer	0.00308	0.006	CcSEcCtD
Methyldopa—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00302	0.0059	CcSEcCtD
Methyldopa—ADRA2A—medulla oblongata—germ cell cancer	0.00302	0.00696	CbGeAlD
Methyldopa—Vasculitis—Methotrexate—germ cell cancer	0.00297	0.00579	CcSEcCtD
Methyldopa—Thrombocytopenia—Vinblastine—germ cell cancer	0.00297	0.00578	CcSEcCtD
Methyldopa—Pancytopenia—Etoposide—germ cell cancer	0.00288	0.00562	CcSEcCtD
Methyldopa—Cardiac disorder—Ifosfamide—germ cell cancer	0.00286	0.00557	CcSEcCtD
Methyldopa—Leukopenia—Bleomycin—germ cell cancer	0.00281	0.00547	CcSEcCtD
Methyldopa—ADRA2A—adrenal gland—germ cell cancer	0.0028	0.00645	CbGeAlD
Methyldopa—Hepatobiliary disease—Cisplatin—germ cell cancer	0.0028	0.00545	CcSEcCtD
Methyldopa—Angiopathy—Ifosfamide—germ cell cancer	0.00279	0.00544	CcSEcCtD
Methyldopa—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00277	0.00541	CcSEcCtD
Methyldopa—ADRA2A—midbrain—germ cell cancer	0.00276	0.00636	CbGeAlD
Methyldopa—Paraesthesia—Vinblastine—germ cell cancer	0.00272	0.0053	CcSEcCtD
Methyldopa—Infestation—Etoposide—germ cell cancer	0.00271	0.00528	CcSEcCtD
Methyldopa—Infestation NOS—Etoposide—germ cell cancer	0.00271	0.00528	CcSEcCtD
Methyldopa—Bradycardia—Cisplatin—germ cell cancer	0.0027	0.00527	CcSEcCtD
Methyldopa—Mental disorder—Ifosfamide—germ cell cancer	0.0027	0.00526	CcSEcCtD
Methyldopa—ADRA2A—spinal cord—germ cell cancer	0.00269	0.00621	CbGeAlD
Methyldopa—Myalgia—Bleomycin—germ cell cancer	0.00267	0.0052	CcSEcCtD
Methyldopa—Jaundice—Etoposide—germ cell cancer	0.00264	0.00515	CcSEcCtD
Methyldopa—Leukopenia—Dactinomycin—germ cell cancer	0.00262	0.0051	CcSEcCtD
Methyldopa—ADRA2A—female gonad—germ cell cancer	0.00261	0.00601	CbGeAlD
Methyldopa—Connective tissue disorder—Cisplatin—germ cell cancer	0.00261	0.00508	CcSEcCtD
Methyldopa—Gynaecomastia—Methotrexate—germ cell cancer	0.00259	0.00506	CcSEcCtD
Methyldopa—Constipation—Vinblastine—germ cell cancer	0.00259	0.00505	CcSEcCtD
Methyldopa—Hepatobiliary disease—Etoposide—germ cell cancer	0.00256	0.00499	CcSEcCtD
Methyldopa—Oedema—Bleomycin—germ cell cancer	0.00256	0.00499	CcSEcCtD
Methyldopa—Infection—Bleomycin—germ cell cancer	0.00254	0.00496	CcSEcCtD
Methyldopa—Agranulocytosis—Etoposide—germ cell cancer	0.00253	0.00493	CcSEcCtD
Methyldopa—Thrombocytopenia—Bleomycin—germ cell cancer	0.00251	0.00488	CcSEcCtD
Methyldopa—Myalgia—Dactinomycin—germ cell cancer	0.00249	0.00485	CcSEcCtD
Methyldopa—Cardiac disorder—Cisplatin—germ cell cancer	0.00246	0.0048	CcSEcCtD
Methyldopa—ADRA2A—endocrine gland—germ cell cancer	0.00243	0.00559	CbGeAlD
Methyldopa—Leukopenia—Ifosfamide—germ cell cancer	0.0024	0.00468	CcSEcCtD
Methyldopa—ADRA2A—head—germ cell cancer	0.00239	0.00552	CbGeAlD
Methyldopa—Mediastinal disorder—Cisplatin—germ cell cancer	0.00239	0.00466	CcSEcCtD
Methyldopa—Oedema—Dactinomycin—germ cell cancer	0.00239	0.00465	CcSEcCtD
Methyldopa—Infection—Dactinomycin—germ cell cancer	0.00237	0.00462	CcSEcCtD
Methyldopa—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00234	0.00456	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00233	0.00455	CcSEcCtD
Methyldopa—ADRA2A—testis—germ cell cancer	0.00231	0.00533	CbGeAlD
Methyldopa—Paraesthesia—Bleomycin—germ cell cancer	0.0023	0.00448	CcSEcCtD
Methyldopa—Myalgia—Ifosfamide—germ cell cancer	0.00228	0.00445	CcSEcCtD
Methyldopa—Arthralgia—Ifosfamide—germ cell cancer	0.00228	0.00445	CcSEcCtD
Methyldopa—Flatulence—Cisplatin—germ cell cancer	0.00228	0.00444	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00227	0.00442	CcSEcCtD
Methyldopa—Cardiac disorder—Etoposide—germ cell cancer	0.00226	0.0044	CcSEcCtD
Methyldopa—Hypersensitivity—Vinblastine—germ cell cancer	0.00223	0.00435	CcSEcCtD
Methyldopa—Angiopathy—Etoposide—germ cell cancer	0.00221	0.0043	CcSEcCtD
Methyldopa—Mediastinal disorder—Etoposide—germ cell cancer	0.00219	0.00427	CcSEcCtD
Methyldopa—Oedema—Ifosfamide—germ cell cancer	0.00219	0.00426	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00217	0.00424	CcSEcCtD
Methyldopa—Asthenia—Vinblastine—germ cell cancer	0.00217	0.00424	CcSEcCtD
Methyldopa—Infection—Ifosfamide—germ cell cancer	0.00217	0.00424	CcSEcCtD
Methyldopa—Nervous system disorder—Ifosfamide—germ cell cancer	0.00214	0.00418	CcSEcCtD
Methyldopa—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00214	0.00417	CcSEcCtD
Methyldopa—ADRA2A—cerebellum—germ cell cancer	0.00214	0.00492	CbGeAlD
Methyldopa—Skin disorder—Ifosfamide—germ cell cancer	0.00212	0.00414	CcSEcCtD
Methyldopa—Diarrhoea—Vinblastine—germ cell cancer	0.00207	0.00404	CcSEcCtD
Methyldopa—Leukopenia—Cisplatin—germ cell cancer	0.00207	0.00403	CcSEcCtD
Methyldopa—Body temperature increased—Bleomycin—germ cell cancer	0.00202	0.00394	CcSEcCtD
Methyldopa—Dizziness—Vinblastine—germ cell cancer	0.002	0.00391	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00199	0.00388	CcSEcCtD
Methyldopa—Myalgia—Cisplatin—germ cell cancer	0.00197	0.00383	CcSEcCtD
Methyldopa—Paraesthesia—Ifosfamide—germ cell cancer	0.00196	0.00383	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00195	0.00381	CcSEcCtD
Methyldopa—Liver function test abnormal—Methotrexate—germ cell cancer	0.00194	0.00379	CcSEcCtD
Methyldopa—Vomiting—Vinblastine—germ cell cancer	0.00193	0.00376	CcSEcCtD
Methyldopa—Breast disorder—Methotrexate—germ cell cancer	0.0019	0.00371	CcSEcCtD
Methyldopa—Headache—Vinblastine—germ cell cancer	0.0019	0.0037	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.0019	0.0037	CcSEcCtD
Methyldopa—Leukopenia—Etoposide—germ cell cancer	0.00189	0.00369	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00189	0.00368	CcSEcCtD
Methyldopa—Body temperature increased—Dactinomycin—germ cell cancer	0.00189	0.00368	CcSEcCtD
Methyldopa—Oedema—Cisplatin—germ cell cancer	0.00189	0.00368	CcSEcCtD
Methyldopa—Hypersensitivity—Bleomycin—germ cell cancer	0.00189	0.00368	CcSEcCtD
Methyldopa—Infection—Cisplatin—germ cell cancer	0.00187	0.00365	CcSEcCtD
Methyldopa—Constipation—Ifosfamide—germ cell cancer	0.00187	0.00365	CcSEcCtD
Methyldopa—Nervous system disorder—Cisplatin—germ cell cancer	0.00185	0.0036	CcSEcCtD
Methyldopa—Thrombocytopenia—Cisplatin—germ cell cancer	0.00185	0.0036	CcSEcCtD
Methyldopa—Asthenia—Bleomycin—germ cell cancer	0.00184	0.00358	CcSEcCtD
Methyldopa—Skin disorder—Cisplatin—germ cell cancer	0.00183	0.00357	CcSEcCtD
Methyldopa—Eosinophilia—Methotrexate—germ cell cancer	0.0018	0.00351	CcSEcCtD
Methyldopa—Nausea—Vinblastine—germ cell cancer	0.0018	0.00351	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00179	0.00349	CcSEcCtD
Methyldopa—Pancreatitis—Methotrexate—germ cell cancer	0.00178	0.00348	CcSEcCtD
Methyldopa—Hypersensitivity—Dactinomycin—germ cell cancer	0.00176	0.00343	CcSEcCtD
Methyldopa—ADRA2A—brain—germ cell cancer	0.00174	0.004	CbGeAlD
Methyldopa—Body temperature increased—Ifosfamide—germ cell cancer	0.00173	0.00337	CcSEcCtD
Methyldopa—Pancytopenia—Methotrexate—germ cell cancer	0.00173	0.00337	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00172	0.00335	CcSEcCtD
Methyldopa—Infection—Etoposide—germ cell cancer	0.00172	0.00335	CcSEcCtD
Methyldopa—Asthenia—Dactinomycin—germ cell cancer	0.00171	0.00334	CcSEcCtD
Methyldopa—Paraesthesia—Cisplatin—germ cell cancer	0.00169	0.0033	CcSEcCtD
Methyldopa—Thrombocytopenia—Etoposide—germ cell cancer	0.00169	0.0033	CcSEcCtD
Methyldopa—Skin disorder—Etoposide—germ cell cancer	0.00168	0.00327	CcSEcCtD
Methyldopa—ADRA2A—lymph node—germ cell cancer	0.00168	0.00386	CbGeAlD
Methyldopa—Erectile dysfunction—Methotrexate—germ cell cancer	0.00168	0.00327	CcSEcCtD
Methyldopa—Diarrhoea—Dactinomycin—germ cell cancer	0.00163	0.00318	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00163	0.00317	CcSEcCtD
Methyldopa—Vomiting—Bleomycin—germ cell cancer	0.00163	0.00317	CcSEcCtD
Methyldopa—Infestation NOS—Methotrexate—germ cell cancer	0.00162	0.00316	CcSEcCtD
Methyldopa—Infestation—Methotrexate—germ cell cancer	0.00162	0.00316	CcSEcCtD
Methyldopa—Rash—Bleomycin—germ cell cancer	0.00161	0.00315	CcSEcCtD
Methyldopa—Dermatitis—Bleomycin—germ cell cancer	0.00161	0.00314	CcSEcCtD
Methyldopa—Hypersensitivity—Ifosfamide—germ cell cancer	0.00161	0.00314	CcSEcCtD
Methyldopa—Asthenia—Ifosfamide—germ cell cancer	0.00157	0.00306	CcSEcCtD
Methyldopa—Paraesthesia—Etoposide—germ cell cancer	0.00155	0.00302	CcSEcCtD
Methyldopa—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00153	0.00299	CcSEcCtD
Methyldopa—Nausea—Bleomycin—germ cell cancer	0.00152	0.00296	CcSEcCtD
Methyldopa—Vomiting—Dactinomycin—germ cell cancer	0.00152	0.00296	CcSEcCtD
Methyldopa—Agranulocytosis—Methotrexate—germ cell cancer	0.00151	0.00295	CcSEcCtD
Methyldopa—Rash—Dactinomycin—germ cell cancer	0.0015	0.00293	CcSEcCtD
Methyldopa—Diarrhoea—Ifosfamide—germ cell cancer	0.0015	0.00292	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00149	0.00291	CcSEcCtD
Methyldopa—Body temperature increased—Cisplatin—germ cell cancer	0.00149	0.00291	CcSEcCtD
Methyldopa—Constipation—Etoposide—germ cell cancer	0.00148	0.00288	CcSEcCtD
Methyldopa—Hepatitis—Methotrexate—germ cell cancer	0.00146	0.00284	CcSEcCtD
Methyldopa—Dizziness—Ifosfamide—germ cell cancer	0.00145	0.00282	CcSEcCtD
Methyldopa—Nausea—Dactinomycin—germ cell cancer	0.00142	0.00276	CcSEcCtD
Methyldopa—Vomiting—Ifosfamide—germ cell cancer	0.00139	0.00271	CcSEcCtD
Methyldopa—Hypersensitivity—Cisplatin—germ cell cancer	0.00139	0.00271	CcSEcCtD
Methyldopa—Rash—Ifosfamide—germ cell cancer	0.00138	0.00269	CcSEcCtD
Methyldopa—Dermatitis—Ifosfamide—germ cell cancer	0.00138	0.00269	CcSEcCtD
Methyldopa—Body temperature increased—Etoposide—germ cell cancer	0.00137	0.00266	CcSEcCtD
Methyldopa—Asthenia—Cisplatin—germ cell cancer	0.00135	0.00264	CcSEcCtD
Methyldopa—Cardiac disorder—Methotrexate—germ cell cancer	0.00135	0.00263	CcSEcCtD
Methyldopa—Angiopathy—Methotrexate—germ cell cancer	0.00132	0.00258	CcSEcCtD
Methyldopa—Mediastinal disorder—Methotrexate—germ cell cancer	0.00131	0.00256	CcSEcCtD
Methyldopa—Nausea—Ifosfamide—germ cell cancer	0.0013	0.00253	CcSEcCtD
Methyldopa—Diarrhoea—Cisplatin—germ cell cancer	0.00129	0.00251	CcSEcCtD
Methyldopa—Mental disorder—Methotrexate—germ cell cancer	0.00128	0.00249	CcSEcCtD
Methyldopa—Hypersensitivity—Etoposide—germ cell cancer	0.00127	0.00248	CcSEcCtD
Methyldopa—Asthenia—Etoposide—germ cell cancer	0.00124	0.00242	CcSEcCtD
Methyldopa—Vomiting—Cisplatin—germ cell cancer	0.0012	0.00234	CcSEcCtD
Methyldopa—Rash—Cisplatin—germ cell cancer	0.00119	0.00232	CcSEcCtD
Methyldopa—Dermatitis—Cisplatin—germ cell cancer	0.00119	0.00232	CcSEcCtD
Methyldopa—Diarrhoea—Etoposide—germ cell cancer	0.00118	0.0023	CcSEcCtD
Methyldopa—Dizziness—Etoposide—germ cell cancer	0.00114	0.00223	CcSEcCtD
Methyldopa—Leukopenia—Methotrexate—germ cell cancer	0.00113	0.00221	CcSEcCtD
Methyldopa—Nausea—Cisplatin—germ cell cancer	0.00112	0.00218	CcSEcCtD
Methyldopa—Vomiting—Etoposide—germ cell cancer	0.0011	0.00214	CcSEcCtD
Methyldopa—Rash—Etoposide—germ cell cancer	0.00109	0.00212	CcSEcCtD
Methyldopa—Dermatitis—Etoposide—germ cell cancer	0.00109	0.00212	CcSEcCtD
Methyldopa—Headache—Etoposide—germ cell cancer	0.00108	0.00211	CcSEcCtD
Methyldopa—Myalgia—Methotrexate—germ cell cancer	0.00108	0.0021	CcSEcCtD
Methyldopa—Arthralgia—Methotrexate—germ cell cancer	0.00108	0.0021	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00107	0.00209	CcSEcCtD
Methyldopa—Infection—Methotrexate—germ cell cancer	0.00103	0.002	CcSEcCtD
Methyldopa—Nausea—Etoposide—germ cell cancer	0.00103	0.002	CcSEcCtD
Methyldopa—Nervous system disorder—Methotrexate—germ cell cancer	0.00101	0.00198	CcSEcCtD
Methyldopa—Thrombocytopenia—Methotrexate—germ cell cancer	0.00101	0.00197	CcSEcCtD
Methyldopa—Skin disorder—Methotrexate—germ cell cancer	0.001	0.00196	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000943	0.00184	CcSEcCtD
Methyldopa—Paraesthesia—Methotrexate—germ cell cancer	0.000929	0.00181	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000893	0.00174	CcSEcCtD
Methyldopa—Body temperature increased—Methotrexate—germ cell cancer	0.000818	0.00159	CcSEcCtD
Methyldopa—Hypersensitivity—Methotrexate—germ cell cancer	0.000762	0.00149	CcSEcCtD
Methyldopa—Asthenia—Methotrexate—germ cell cancer	0.000742	0.00145	CcSEcCtD
Methyldopa—Diarrhoea—Methotrexate—germ cell cancer	0.000708	0.00138	CcSEcCtD
Methyldopa—Dizziness—Methotrexate—germ cell cancer	0.000684	0.00133	CcSEcCtD
Methyldopa—Vomiting—Methotrexate—germ cell cancer	0.000658	0.00128	CcSEcCtD
Methyldopa—Rash—Methotrexate—germ cell cancer	0.000652	0.00127	CcSEcCtD
Methyldopa—Dermatitis—Methotrexate—germ cell cancer	0.000652	0.00127	CcSEcCtD
Methyldopa—Headache—Methotrexate—germ cell cancer	0.000648	0.00126	CcSEcCtD
Methyldopa—Nausea—Methotrexate—germ cell cancer	0.000615	0.0012	CcSEcCtD
